In today’s session Mylan NV (MYL) recorded an unusually high (359) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the April, 2017 put, expecting serious MYL decrease. With 359 contracts traded and 4604 open interest for the Apr, 17 contract, it seems this is a quite bearish bet. The option with symbol: MYL170421P00037500 closed last at: $3.85 or 4.1% up. About 6.05M shares traded hands. Mylan NV (NASDAQ:MYL) has declined 17.06% since March 1, 2016 and is downtrending. It has underperformed by 26.31% the S&P500.
Analysts await Mylan NV (NASDAQ:MYL) to report earnings on November, 4. They expect $1.60 EPS, up 11.89% or $0.17 from last year’s $1.43 per share. MYL’s profit will be $857.41 million for 5.92 P/E if the $1.60 EPS becomes a reality. After $1.16 actual EPS reported by Mylan NV for the previous quarter, Wall Street now forecasts 37.93% EPS growth.
Mylan NV (NASDAQ:MYL) Ratings Coverage
Out of 13 analysts covering Mylan Inc. (NASDAQ:MYL), 7 rate it a “Buy”, 0 “Sell”, while 6 “Hold”. This means 54% are positive. $85 is the highest target while $46 is the lowest. The $60.62 average target is 59.95% above today’s ($37.9) stock price. Mylan Inc. has been the topic of 24 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The firm has “Hold” rating given on Thursday, August 27 by Zacks. RBC Capital Markets maintained Mylan NV (NASDAQ:MYL) rating on Tuesday, September 6. RBC Capital Markets has “Sector Perform” rating and $48 price target. The firm earned “Buy” rating on Monday, August 17 by Zacks. The company was maintained on Friday, August 7 by Deutsche Bank. The stock of Mylan NV (NASDAQ:MYL) has “Buy” rating given on Friday, August 7 by Argus Research. The firm has “Equal-Weight” rating given on Thursday, December 3 by Morgan Stanley. As per Wednesday, August 19, the company rating was maintained by BTIG Research. The stock has “Buy” rating given by Deutsche Bank on Tuesday, July 28. On Monday, July 27 the stock rating was downgraded by Cowen & Co to “Market Perform”. Leerink Swann maintained it with “Outperform” rating and $60 target price in Saturday, August 29 report.
Insitutional Activity: The institutional sentiment decreased to 0.45 in Q2 2016. Its down 0.05, from 0.5 in 2016Q1. The ratio dropped, as 6 funds sold all Mylan NV shares owned while 5 reduced positions. 1 funds bought stakes while 4 increased positions. They now own 533,685 shares or 37.96% less from 860,251 shares in 2016Q1.
& Mgmt Co last reported 1,600 shares in the company. Gemmer Asset Management Lc has 0% invested in the company for 21 shares. The Colorado-based Icon Advisers has invested 0.1% in Mylan NV (NASDAQ:MYL). Covington Cap Management has 0.16% invested in the company for 39,339 shares. Moreover, Eagle Asset Mngmt has 0.02% invested in Mylan NV (NASDAQ:MYL) for 56,209 shares. Vantage Investment Advsr Ltd Co has 712 shares for 0.01% of their US portfolio. Gulf Intl Bank & Trust (Uk) Ltd owns 123,183 shares or 0.09% of their US portfolio. The West Virginia-based Ntv Asset Mngmt Lc has invested 0.26% in Mylan NV (NASDAQ:MYL). Westport Res holds 0.37% or 26,765 shares in its portfolio. Novare Mgmt Limited Liability Com accumulated 0.93% or 79,851 shares. Jacobs And Communication Ca last reported 0.07% of its portfolio in the stock. Princeton Portfolio Strategies Limited Liability last reported 1.89% of its portfolio in the stock.
Mylan N.V. is a global pharmaceutical company. The company has a market cap of $20.31 billion. The Firm develops, licenses, makes, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients . It has a 24.14 P/E ratio. It operates through two divisions: Generics and Specialty.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.